{"entity":{"type":"insider","cik":"0001780030","url":"/insider/0001780030","json_url":"/insider/0001780030.json","name":"STEPHENSON BRIAN C","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":71,"n_filings":31,"first":"2019-07-03","last":"2026-07-01","span_basis":"filed_date"},"name_variants":[{"name":"STEPHENSON BRIAN C","source":"filing","n_filings":31,"first_seen":"2019-07-03","last_seen":"2026-07-01"}],"transactions":[{"id":5923707,"accession":"0001780030-26-000006","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001780030-26-000006","line_url":"/filing/0001780030-26-000006","is_derivative":false,"issuer_cik":"0001780030","issuer_name":"Faeth Therapeutics, Inc.","issuer_ticker":"FTH","issuer_name_source":null,"issuer_url":"/issuer/0001780030","owner_cik":"0001780030","owner_name":"STEPHENSON BRIAN C","owner_display_name":"STEPHENSON BRIAN C","owner_url":"/insider/0001780030","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":23.4984,"price_display":"23.50","price_state":"stated","total_value":117492.0,"total_display":"117,492.00","total_whole":"117,492","shares_owned_after":46088.0,"shares_owned_after_display":"46,088","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-07-01","filed_date":"2026-07-01","scope":"insider","n_lines":2},{"id":5923703,"accession":"0001780030-26-000006","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001780030-26-000006","line_url":"/filing/0001780030-26-000006","is_derivative":false,"issuer_cik":"0001780030","issuer_name":"Faeth Therapeutics, Inc.","issuer_ticker":"FTH","issuer_name_source":null,"issuer_url":"/issuer/0001780030","owner_cik":"0001780030","owner_name":"STEPHENSON BRIAN C","owner_display_name":"STEPHENSON BRIAN C","owner_url":"/insider/0001780030","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7803.0,"shares_display":"7,803","price_per_share":24.252190183262847,"price_display":"24.25","price_state":"stated","total_value":189239.84,"total_display":"189,239.84","total_whole":"189,240","shares_owned_after":41688.0,"shares_owned_after_display":"41,688","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-06-30","filed_date":"2026-07-01","scope":"insider","n_lines":3},{"id":5923698,"accession":"0001780030-26-000006","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001780030-26-000006","line_url":"/filing/0001780030-26-000006#line-1","is_derivative":false,"issuer_cik":"0001780030","issuer_name":"Faeth Therapeutics, Inc.","issuer_ticker":"FTH","issuer_name_source":null,"issuer_url":"/issuer/0001780030","owner_cik":"0001780030","owner_name":"STEPHENSON BRIAN C","owner_display_name":"STEPHENSON BRIAN C","owner_url":"/insider/0001780030","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":831.0,"shares_display":"831","price_per_share":23.34,"price_display":"23.34","price_state":"stated","total_value":19395.54,"total_display":"19,395.54","total_whole":"19,396","shares_owned_after":33885.0,"shares_owned_after_display":"33,885","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-06-29","filed_date":"2026-07-01","scope":"insider"},{"id":5899809,"accession":"0001780030-26-000005","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001780030-26-000005","line_url":"/filing/0001780030-26-000005","is_derivative":false,"issuer_cik":"0001780030","issuer_name":"Faeth Therapeutics, Inc.","issuer_ticker":"FTH","issuer_name_source":null,"issuer_url":"/issuer/0001780030","owner_cik":"0001780030","owner_name":"STEPHENSON BRIAN C","owner_display_name":"STEPHENSON BRIAN C","owner_url":"/insider/0001780030","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6250.0,"shares_display":"6,250","price_per_share":24.94536,"price_display":"24.95","price_state":"stated","total_value":155908.5,"total_display":"155,908.50","total_whole":"155,909","shares_owned_after":31596.0,"shares_owned_after_display":"31,596","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-06-26","filed_date":"2026-06-26","scope":"insider","n_lines":4},{"id":5899804,"accession":"0001780030-26-000005","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001780030-26-000005","line_url":"/filing/0001780030-26-000005","is_derivative":false,"issuer_cik":"0001780030","issuer_name":"Faeth Therapeutics, Inc.","issuer_ticker":"FTH","issuer_name_source":null,"issuer_url":"/issuer/0001780030","owner_cik":"0001780030","owner_name":"STEPHENSON BRIAN C","owner_display_name":"STEPHENSON BRIAN C","owner_url":"/insider/0001780030","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":9391.0,"shares_display":"9,391","price_per_share":26.127145138962838,"price_display":"26.13","price_state":"stated","total_value":245360.02,"total_display":"245,360.02","total_whole":"245,360","shares_owned_after":26704.0,"shares_owned_after_display":"26,704","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-06-24","filed_date":"2026-06-26","scope":"insider","n_lines":4},{"id":5771136,"accession":"0001780030-26-000004","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001780030-26-000004","line_url":"/filing/0001780030-26-000004","is_derivative":false,"issuer_cik":"0001780030","issuer_name":"Faeth Therapeutics, Inc.","issuer_ticker":"FTH","issuer_name_source":null,"issuer_url":"/issuer/0001780030","owner_cik":"0001780030","owner_name":"STEPHENSON BRIAN C","owner_display_name":"STEPHENSON BRIAN C","owner_url":"/insider/0001780030","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":9230.0,"shares_display":"9,230","price_per_share":24.35601625135428,"price_display":"24.36","price_state":"stated","total_value":224806.03,"total_display":"224,806.03","total_whole":"224,806","shares_owned_after":15019.0,"shares_owned_after_display":"15,019","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-06-23","filed_date":"2026-06-24","scope":"insider","n_lines":3},{"id":5771130,"accession":"0001780030-26-000004","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001780030-26-000004","line_url":"/filing/0001780030-26-000004","is_derivative":false,"issuer_cik":"0001780030","issuer_name":"Faeth Therapeutics, Inc.","issuer_ticker":"FTH","issuer_name_source":null,"issuer_url":"/issuer/0001780030","owner_cik":"0001780030","owner_name":"STEPHENSON BRIAN C","owner_display_name":"STEPHENSON BRIAN C","owner_url":"/insider/0001780030","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":8183.0,"shares_display":"8,183","price_per_share":22.133030673347182,"price_display":"22.13","price_state":"stated","total_value":181114.59,"total_display":"181,114.59","total_whole":"181,115","shares_owned_after":7827.0,"shares_owned_after_display":"7,827","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-06-22","filed_date":"2026-06-24","scope":"insider","n_lines":5},{"id":4872506,"accession":"0000950170-25-029262","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000950170-25-029262","line_url":"/filing/0000950170-25-029262","is_derivative":false,"issuer_cik":"0001743881","issuer_name":"BridgeBio Pharma, Inc.","issuer_ticker":"BBIO","issuer_name_source":null,"issuer_url":"/issuer/0001743881","owner_cik":"0001780030","owner_name":"STEPHENSON BRIAN C","owner_display_name":"STEPHENSON BRIAN C","owner_url":"/insider/0001780030","role":"Officer (CFO and Treasurer)","role_mark":"O","role_mark_label":"Officer (CFO and Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO and Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8500.0,"shares_display":"8,500","price_per_share":33.18998588235294,"price_display":"33.19","price_state":"stated","total_value":282114.88,"total_display":"282,114.88","total_whole":"282,115","shares_owned_after":102564.0,"shares_owned_after_display":"102,564","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-25","filed_date":"2025-02-27","scope":"insider","n_lines":2},{"id":4944983,"accession":"0000950170-25-023630","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000950170-25-023630","line_url":"/filing/0000950170-25-023630#line-3","is_derivative":false,"issuer_cik":"0001743881","issuer_name":"BridgeBio Pharma, Inc.","issuer_ticker":"BBIO","issuer_name_source":null,"issuer_url":"/issuer/0001743881","owner_cik":"0001780030","owner_name":"STEPHENSON BRIAN C","owner_display_name":"STEPHENSON BRIAN C","owner_url":"/insider/0001780030","role":"Officer (Secretary, Treasurer & CFO)","role_mark":"O","role_mark_label":"Officer (Secretary, Treasurer & CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Secretary, Treasurer & CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4148.0,"shares_display":"4,148","price_per_share":36.1556,"price_display":"36.16","price_state":"stated","total_value":149973.4288,"total_display":"149,973.43","total_whole":"149,973","shares_owned_after":102464.0,"shares_owned_after_display":"102,464","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-19","filed_date":"2025-02-19","scope":"insider"},{"id":4659372,"accession":"0000950170-25-011242","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-25-011242","line_url":"/filing/0000950170-25-011242#line-2","is_derivative":false,"issuer_cik":"0001743881","issuer_name":"BridgeBio Pharma, Inc.","issuer_ticker":"BBIO","issuer_name_source":null,"issuer_url":"/issuer/0001743881","owner_cik":"0001780030","owner_name":"STEPHENSON BRIAN C","owner_display_name":"STEPHENSON BRIAN C","owner_url":"/insider/0001780030","role":"Officer (Secretary, Treasurer & CFO)","role_mark":"O","role_mark_label":"Officer (Secretary, Treasurer & CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Secretary, Treasurer & CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":68000.0,"shares_display":"68,000","price_per_share":36.2906,"price_display":"36.29","price_state":"stated","total_value":2467760.8,"total_display":"2,467,760.80","total_whole":"2,467,761","shares_owned_after":93758.0,"shares_owned_after_display":"93,758","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-28","filed_date":"2025-01-30","scope":"insider"},{"id":3228409,"accession":"0000950170-24-129452","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-129452","line_url":"/filing/0000950170-24-129452#line-1","is_derivative":false,"issuer_cik":"0001743881","issuer_name":"BridgeBio Pharma, Inc.","issuer_ticker":"BBIO","issuer_name_source":null,"issuer_url":"/issuer/0001743881","owner_cik":"0001780030","owner_name":"STEPHENSON BRIAN C","owner_display_name":"STEPHENSON BRIAN C","owner_url":"/insider/0001780030","role":"Officer (Secretary, Treasurer & CFO)","role_mark":"O","role_mark_label":"Officer (Secretary, Treasurer & CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Secretary, Treasurer & CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4156.0,"shares_display":"4,156","price_per_share":22.4102,"price_display":"22.41","price_state":"stated","total_value":93136.7912,"total_display":"93,136.79","total_whole":"93,137","shares_owned_after":93758.0,"shares_owned_after_display":"93,758","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-19","filed_date":"2024-11-20","scope":"insider"},{"id":2277015,"accession":"0000950170-24-099269","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000950170-24-099269","line_url":"/filing/0000950170-24-099269","is_derivative":false,"issuer_cik":"0001743881","issuer_name":"BridgeBio Pharma, Inc.","issuer_ticker":"BBIO","issuer_name_source":null,"issuer_url":"/issuer/0001743881","owner_cik":"0001780030","owner_name":"STEPHENSON BRIAN C","owner_display_name":"STEPHENSON BRIAN C","owner_url":"/insider/0001780030","role":"Officer (Secretary, Treasurer & CFO)","role_mark":"O","role_mark_label":"Officer (Secretary, Treasurer & CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Secretary, Treasurer & CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4155.0,"shares_display":"4,155","price_per_share":24.690620216606497,"price_display":"24.69","price_state":"stated","total_value":102589.527,"total_display":"102,589.53","total_whole":"102,590","shares_owned_after":86890.0,"shares_owned_after_display":"86,890","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-19","filed_date":"2024-08-20","scope":"insider","n_lines":2},{"id":8753874,"accession":"0001209191-23-056015","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-23-056015","line_url":"/filing/0001209191-23-056015#line-3","is_derivative":false,"issuer_cik":"0001743881","issuer_name":"BridgeBio Pharma, Inc.","issuer_ticker":"BBIO","issuer_name_source":null,"issuer_url":"/issuer/0001743881","owner_cik":"0001780030","owner_name":"STEPHENSON BRIAN C","owner_display_name":"STEPHENSON BRIAN C","owner_url":"/insider/0001780030","role":"Officer (Secretary, Treasurer & CFO)","role_mark":"O","role_mark_label":"Officer (Secretary, Treasurer & CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Secretary, Treasurer & CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":22685.0,"shares_display":"22,685","price_per_share":29.0967,"price_display":"29.10","price_state":"stated","total_value":660058.6395,"total_display":"660,058.64","total_whole":"660,059","shares_owned_after":36710.0,"shares_owned_after_display":"36,710","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-17","filed_date":"2023-11-20","scope":"insider"},{"id":8189453,"accession":"0001209191-23-046512","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-23-046512","line_url":"/filing/0001209191-23-046512#line-3","is_derivative":false,"issuer_cik":"0001743881","issuer_name":"BridgeBio Pharma, Inc.","issuer_ticker":"BBIO","issuer_name_source":null,"issuer_url":"/issuer/0001743881","owner_cik":"0001780030","owner_name":"STEPHENSON BRIAN C","owner_display_name":"STEPHENSON BRIAN C","owner_url":"/insider/0001780030","role":"Officer (Secretary, Treasurer & CFO)","role_mark":"O","role_mark_label":"Officer (Secretary, Treasurer & CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Secretary, Treasurer & CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":22683.0,"shares_display":"22,683","price_per_share":28.5877,"price_display":"28.59","price_state":"stated","total_value":648454.7991,"total_display":"648,454.80","total_whole":"648,455","shares_owned_after":36710.0,"shares_owned_after_display":"36,710","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-17","filed_date":"2023-08-18","scope":"insider"},{"id":8220470,"accession":"0001209191-23-030581","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-23-030581","line_url":"/filing/0001209191-23-030581#line-3","is_derivative":false,"issuer_cik":"0001743881","issuer_name":"BridgeBio Pharma, Inc.","issuer_ticker":"BBIO","issuer_name_source":null,"issuer_url":"/issuer/0001743881","owner_cik":"0001780030","owner_name":"STEPHENSON BRIAN C","owner_display_name":"STEPHENSON BRIAN C","owner_url":"/insider/0001780030","role":"Officer (Secretary, Treasurer & CFO)","role_mark":"O","role_mark_label":"Officer (Secretary, Treasurer & CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Secretary, Treasurer & CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":24424.0,"shares_display":"24,424","price_per_share":14.0095,"price_display":"14.01","price_state":"stated","total_value":342168.028,"total_display":"342,168.03","total_whole":"342,168","shares_owned_after":36408.0,"shares_owned_after_display":"36,408","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-17","filed_date":"2023-05-18","scope":"insider"},{"id":8723555,"accession":"0001209191-23-027626","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-027626","line_url":"/filing/0001209191-23-027626#line-1","is_derivative":false,"issuer_cik":"0001743881","issuer_name":"BridgeBio Pharma, Inc.","issuer_ticker":"BBIO","issuer_name_source":null,"issuer_url":"/issuer/0001743881","owner_cik":"0001780030","owner_name":"STEPHENSON BRIAN C","owner_display_name":"STEPHENSON BRIAN C","owner_url":"/insider/0001780030","role":"Officer (Secretary, Treasurer & CFO)","role_mark":"O","role_mark_label":"Officer (Secretary, Treasurer & CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Secretary, Treasurer & CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":64929.0,"shares_display":"64,929","price_per_share":14.18,"price_display":"14.18","price_state":"stated","total_value":920693.22,"total_display":"920,693.22","total_whole":"920,693","shares_owned_after":36408.0,"shares_owned_after_display":"36,408","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-03","filed_date":"2023-05-05","scope":"insider"},{"id":7950380,"accession":"0001209191-23-023808","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-023808","line_url":"/filing/0001209191-23-023808#line-1","is_derivative":false,"issuer_cik":"0001743881","issuer_name":"BridgeBio Pharma, Inc.","issuer_ticker":"BBIO","issuer_name_source":null,"issuer_url":"/issuer/0001743881","owner_cik":"0001780030","owner_name":"STEPHENSON BRIAN C","owner_display_name":"STEPHENSON BRIAN C","owner_url":"/insider/0001780030","role":"Officer (Secretary, Treasurer & CFO)","role_mark":"O","role_mark_label":"Officer (Secretary, Treasurer & CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Secretary, Treasurer & CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":55500.0,"shares_display":"55,500","price_per_share":15.454,"price_display":"15.45","price_state":"stated","total_value":857697.0,"total_display":"857,697.00","total_whole":"857,697","shares_owned_after":101337.0,"shares_owned_after_display":"101,337","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-04-05","filed_date":"2023-04-07","scope":"insider"},{"id":8249305,"accession":"0001209191-23-016060","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-016060","line_url":"/filing/0001209191-23-016060#line-1","is_derivative":false,"issuer_cik":"0001743881","issuer_name":"BridgeBio Pharma, Inc.","issuer_ticker":"BBIO","issuer_name_source":null,"issuer_url":"/issuer/0001743881","owner_cik":"0001780030","owner_name":"STEPHENSON BRIAN C","owner_display_name":"STEPHENSON BRIAN C","owner_url":"/insider/0001780030","role":"Officer (Secretary, Treasurer & CFO)","role_mark":"O","role_mark_label":"Officer (Secretary, Treasurer & CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Secretary, Treasurer & CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":62692.0,"shares_display":"62,692","price_per_share":10.9607,"price_display":"10.96","price_state":"stated","total_value":687148.2044,"total_display":"687,148.20","total_whole":"687,148","shares_owned_after":156837.0,"shares_owned_after_display":"156,837","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-03","filed_date":"2023-03-03","scope":"insider"},{"id":8722738,"accession":"0001209191-23-011450","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-23-011450","line_url":"/filing/0001209191-23-011450","is_derivative":false,"issuer_cik":"0001743881","issuer_name":"BridgeBio Pharma, Inc.","issuer_ticker":"BBIO","issuer_name_source":null,"issuer_url":"/issuer/0001743881","owner_cik":"0001780030","owner_name":"STEPHENSON BRIAN C","owner_display_name":"STEPHENSON BRIAN C","owner_url":"/insider/0001780030","role":"Officer (Secretary, Treasurer & CFO)","role_mark":"O","role_mark_label":"Officer (Secretary, Treasurer & CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Secretary, Treasurer & CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17717.0,"shares_display":"17,717","price_per_share":12.703387960715697,"price_display":"12.70","price_state":"stated","total_value":225065.9245,"total_display":"225,065.92","total_whole":"225,066","shares_owned_after":221679.0,"shares_owned_after_display":"221,679","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-17","filed_date":"2023-02-21","scope":"insider","n_lines":2},{"id":8573438,"accession":"0001209191-23-007381","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-007381","line_url":"/filing/0001209191-23-007381#line-1","is_derivative":false,"issuer_cik":"0001743881","issuer_name":"BridgeBio Pharma, Inc.","issuer_ticker":"BBIO","issuer_name_source":null,"issuer_url":"/issuer/0001743881","owner_cik":"0001780030","owner_name":"STEPHENSON BRIAN C","owner_display_name":"STEPHENSON BRIAN C","owner_url":"/insider/0001780030","role":"Officer (Secretary, Treasurer & CFO)","role_mark":"O","role_mark_label":"Officer (Secretary, Treasurer & CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Secretary, Treasurer & CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":61040.0,"shares_display":"61,040","price_per_share":11.0079,"price_display":"11.01","price_state":"stated","total_value":671922.216,"total_display":"671,922.22","total_whole":"671,922","shares_owned_after":219184.0,"shares_owned_after_display":"219,184","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-03","filed_date":"2023-02-06","scope":"insider"},{"id":8626939,"accession":"0001209191-23-002488","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-002488","line_url":"/filing/0001209191-23-002488#line-1","is_derivative":false,"issuer_cik":"0001743881","issuer_name":"BridgeBio Pharma, Inc.","issuer_ticker":"BBIO","issuer_name_source":null,"issuer_url":"/issuer/0001743881","owner_cik":"0001780030","owner_name":"STEPHENSON BRIAN C","owner_display_name":"STEPHENSON BRIAN C","owner_url":"/insider/0001780030","role":"Officer (Secretary, Treasurer & CFO)","role_mark":"O","role_mark_label":"Officer (Secretary, Treasurer & CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Secretary, Treasurer & CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":61040.0,"shares_display":"61,040","price_per_share":7.6748,"price_display":"7.67","price_state":"stated","total_value":468469.792,"total_display":"468,469.79","total_whole":"468,470","shares_owned_after":280224.0,"shares_owned_after_display":"280,224","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-05","filed_date":"2023-01-06","scope":"insider"},{"id":6575041,"accession":"0001209191-22-057984","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-22-057984","line_url":"/filing/0001209191-22-057984#line-3","is_derivative":false,"issuer_cik":"0001743881","issuer_name":"BridgeBio Pharma, Inc.","issuer_ticker":"BBIO","issuer_name_source":null,"issuer_url":"/issuer/0001743881","owner_cik":"0001780030","owner_name":"STEPHENSON BRIAN C","owner_display_name":"STEPHENSON BRIAN C","owner_url":"/insider/0001780030","role":"Officer (Secretary, Treasurer & CFO)","role_mark":"O","role_mark_label":"Officer (Secretary, Treasurer & CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Secretary, Treasurer & CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19678.0,"shares_display":"19,678","price_per_share":9.4006,"price_display":"9.40","price_state":"stated","total_value":184985.0068,"total_display":"184,985.01","total_whole":"184,985","shares_owned_after":341264.0,"shares_owned_after_display":"341,264","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-17","filed_date":"2022-11-18","scope":"insider"},{"id":4811508,"accession":"0000899243-21-007227","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-21-007227","line_url":"/filing/0000899243-21-007227#line-3","is_derivative":false,"issuer_cik":"0001743881","issuer_name":"BridgeBio Pharma, Inc.","issuer_ticker":"BBIO","issuer_name_source":null,"issuer_url":"/issuer/0001743881","owner_cik":"0001780030","owner_name":"STEPHENSON BRIAN C","owner_display_name":"STEPHENSON BRIAN C","owner_url":"/insider/0001780030","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":8000.0,"shares_display":"8,000","price_per_share":62.5,"price_display":"62.50","price_state":"stated","total_value":500000.0,"total_display":"500,000.00","total_whole":"500,000","shares_owned_after":300043.0,"shares_owned_after_display":"300,043","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-17","filed_date":"2021-02-18","scope":"insider"},{"id":2287749,"accession":"0000899243-20-021557","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-20-021557","line_url":"/filing/0000899243-20-021557","is_derivative":false,"issuer_cik":"0001743881","issuer_name":"BridgeBio Pharma, Inc.","issuer_ticker":"BBIO","issuer_name_source":null,"issuer_url":"/issuer/0001743881","owner_cik":"0001780030","owner_name":"STEPHENSON BRIAN C","owner_display_name":"STEPHENSON BRIAN C","owner_url":"/insider/0001780030","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2539.0,"shares_display":"2,539","price_per_share":27.253372469476172,"price_display":"27.25","price_state":"stated","total_value":69196.3127,"total_display":"69,196.31","total_whole":"69,196","shares_owned_after":287519.0,"shares_owned_after_display":"287,519","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-04","filed_date":"2020-08-05","scope":"insider","n_lines":2},{"id":2287744,"accession":"0000899243-20-021557","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-20-021557","line_url":"/filing/0000899243-20-021557","is_derivative":false,"issuer_cik":"0001743881","issuer_name":"BridgeBio Pharma, Inc.","issuer_ticker":"BBIO","issuer_name_source":null,"issuer_url":"/issuer/0001743881","owner_cik":"0001780030","owner_name":"STEPHENSON BRIAN C","owner_display_name":"STEPHENSON BRIAN C","owner_url":"/insider/0001780030","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4661.0,"shares_display":"4,661","price_per_share":27.267180240291783,"price_display":"27.27","price_state":"stated","total_value":127092.3271,"total_display":"127,092.33","total_whole":"127,092","shares_owned_after":289855.0,"shares_owned_after_display":"289,855","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-03","filed_date":"2020-08-05","scope":"insider","n_lines":2},{"id":2678422,"accession":"0000899243-20-018485","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-20-018485","line_url":"/filing/0000899243-20-018485","is_derivative":false,"issuer_cik":"0001743881","issuer_name":"BridgeBio Pharma, Inc.","issuer_ticker":"BBIO","issuer_name_source":null,"issuer_url":"/issuer/0001743881","owner_cik":"0001780030","owner_name":"STEPHENSON BRIAN C","owner_display_name":"STEPHENSON BRIAN C","owner_url":"/insider/0001780030","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10800.0,"shares_display":"10,800","price_per_share":30.930802777777778,"price_display":"30.93","price_state":"stated","total_value":334052.67,"total_display":"334,052.67","total_whole":"334,053","shares_owned_after":297216.0,"shares_owned_after_display":"297,216","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-07-01","filed_date":"2020-07-06","scope":"insider","n_lines":3},{"id":2857514,"accession":"0000899243-20-015951","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-20-015951","line_url":"/filing/0000899243-20-015951#line-1","is_derivative":false,"issuer_cik":"0001743881","issuer_name":"BridgeBio Pharma, Inc.","issuer_ticker":"BBIO","issuer_name_source":null,"issuer_url":"/issuer/0001743881","owner_cik":"0001780030","owner_name":"STEPHENSON BRIAN C","owner_display_name":"STEPHENSON BRIAN C","owner_url":"/insider/0001780030","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":30.0008,"price_display":"30.00","price_state":"stated","total_value":60001.6,"total_display":"60,001.60","total_whole":"60,002","shares_owned_after":305116.0,"shares_owned_after_display":"305,116","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-08","filed_date":"2020-06-10","scope":"insider"},{"id":3161555,"accession":"0000899243-20-015540","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-20-015540","line_url":"/filing/0000899243-20-015540#line-1","is_derivative":false,"issuer_cik":"0001743881","issuer_name":"BridgeBio Pharma, Inc.","issuer_ticker":"BBIO","issuer_name_source":null,"issuer_url":"/issuer/0001743881","owner_cik":"0001780030","owner_name":"STEPHENSON BRIAN C","owner_display_name":"STEPHENSON BRIAN C","owner_url":"/insider/0001780030","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1600.0,"shares_display":"1,600","price_per_share":30.0449,"price_display":"30.04","price_state":"stated","total_value":48071.84,"total_display":"48,071.84","total_whole":"48,072","shares_owned_after":307116.0,"shares_owned_after_display":"307,116","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-03","filed_date":"2020-06-05","scope":"insider"}],"collapsed":true,"next_cursor":"2020-06-03|3161555","ledger_fault":false,"count":{"value":71,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":24,"open_market":true},{"code":"S","label":"Open-market sale","n":47,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":71},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001829802","name":"Faeth Therapeutics, Inc.","url":"/issuer/0001829802","role":"Officer (Chief Financial Officer)","n_filings":3,"first_seen":"2026-06-24","last_seen":"2026-07-01"},{"type":"issuer","type_label":"ISSUER","cik":"0001743881","name":"BridgeBio Pharma, Inc.","url":"/issuer/0001743881","role":"Officer (CFO and Treasurer)","n_filings":28,"first_seen":"2019-07-03","last_seen":"2025-02-27"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001780030","retrieved_at":"2026-08-27T16:53:03+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-26","last_ingest":"2026-08-27T05:24:39.644631+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}